US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Xtrackers Nifty 500 India ETF

23.03

-0.1150-0.50%

Volume:411

Turnover:9.49K

Market Cap:4.61M

PE:- -

High:23.03

Open:23.03

Low:23.03

Close:23.15

52wk High:27.40

52wk Low:20.52

Shares:200.00K

Float Shares:200.00K

Volume Ratio:1.43

T/O Rate:0.21%

Dividend:0.08

Dividend Rate:0.34%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Clearmind Medicine Completes Dosing for Part A of its of FDA-Regulated Phase I/II Clinical Trial

XBiotech to enroll patients in vilamakitug trial following FDA review

XBiotech Launches Phase II Clinical Trial Evaluating Vilamakitug for the Treatment of Active Axial Spondyloarthritis

HBM Holdings (SEHK:2142) Stock Valuation After New IND Milestone For Cancer Antibody HBM7004

Simply Wall St.

Shanghai Bao Pharma Wins U.S. FDA IND Clearance for First Subcutaneous Ceftriaxone Candidate

HBM Wins China IND Nod for Bispecific Cancer Antibody HBM7004

Antengene Secures China IND Approval for Autoimmune Disease Drug

MT Newswires Live

Antengene Wins China IND Nod for ATG-201 Autoimmune Trial

ANTENGENE-B Receives Chinese IND Approval for ATG-201 in Autoimmune Disease Treatment

Antelopus Selan Energy Secures IND A/Stable and IND A1 Ratings for INR 3,000 Million Loan Facilities

India Ratings Affirms RSWM at IND A, Revises Outlook to Stable

Modi's Third Term: India's Economic Growth Story Faces Its Most Severe Test Yet

Haisco Pharmaceutical Receives IND Application Acceptance for Novel Pain Drug HSK51155

Chery Clarifies Nature of Partnership with Tata Group, Confirms No Direct Investment or Tech Transfer in India

World Gold Council Analyzes Impact of India's Tightened Gold Import Policies

USD/INR Holds High Amidst Fed Rate Hike Fears and Oil Price Surge

India's Central Bank Holds Rates, Unveils Measures to Support Rupee Amid Depreciation

Reserve Bank of India Holds Rates Steady Amid Inflation and Growth Forecast Revisions

India's Central Bank Holds Key Interest Rate Steady, Signaling Reluctance to Hike for Rupee Support

India's Economic Resilience Tested by Energy Crisis

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/IND/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IND","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IND\",,,,,undefined,":{"symbol":"IND","market":"US","secType":"STK","nameCN":"Xtrackers Nifty 500 India ETF","latestPrice":23.03,"timestamp":1788286239651,"preClose":23.145,"halted":0,"volume":411,"delay":0,"changeRate":-0.004968675739900559,"floatShares":200001,"shares":200001,"eps":0,"marketStatus":"Trading","change":-0.115,"latestTime":"09-01 14:12:03 EDT","open":23.03,"high":23.03,"low":23.03,"amount":9489.606125999999,"amplitude":0,"askPrice":23.14,"askSize":100,"bidPrice":23.02,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788292800000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":23.145,"sharesOutstanding":200001,"nav":23.107,"aum":4621406.79,"dividendRate":0.003426,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":23.115,"preClose":23.145,"latestTime":"16:10 EDT","volume":7,"amount":162.015,"timestamp":1788207004404,"change":-0.03,"changeRate":-0.001296,"amplitude":0},"volumeRatio":1.434639},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IND\",,,,,undefined,":{"symbol":"IND","floatShares":200001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.434639,"shares":200001,"dividePrice":0.0789,"high":23.03,"amplitude":0,"preClose":23.145,"low":23.03,"week52Low":20.515,"pbRate":"--","week52High":27.4,"institutionHeld":0,"latestPrice":23.03,"eps":0,"divideRate":0.003426,"volume":411,"delay":0,"ttmEps":0,"open":23.03,"prevYearClose":24.78,"prevWeekClose":23.1583,"prevMonthClose":23.145,"prevQuarterClose":22.88,"fiveDayClose":23.391,"twentyDayClose":23.285,"sixtyDayClose":22.2234},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IND\",params:#limit:5,,,undefined,":[{"date":"2026-06-18","symbol":"IND","amount":0.07775,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-18","defaultRemindTime":1781789400000,"name":"Xtrackers Nifty 500 India ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-18","currency":"USD","dateTimestamp":1781755200000,"payDate":"2026-06-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IND\",market:\"US\",,,undefined,":[{"executeDate":"2026-06-18","recordDate":"2026-06-18","paymentDate":"2026-06-26","value":0.07775,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IND\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IND\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2643517217","title":"Clearmind Medicine Completes Dosing for Part A of its of FDA-Regulated Phase I/II Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2643517217","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643517217?lang=en_us&edition=fundamental","pubTime":"2026-06-16 19:32","pubTimestamp":1781609520,"startTime":"0","endTime":"0","summary":"Vancouver, Canada, June  16, 2026  (GLOBE NEWSWIRE) --  Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on the discovery and development","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/16/3312463/0/en/Clearmind-Medicine-Completes-Dosing-for-Part-A-of-its-of-FDA-Regulated-Phase-I-II-Clinical-Trial.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","IND","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643508209","title":"XBiotech to enroll patients in vilamakitug trial following FDA review","url":"https://stock-news.laohu8.com/highlight/detail?id=2643508209","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643508209?lang=en_us&edition=fundamental","pubTime":"2026-06-15 21:21","pubTimestamp":1781529699,"startTime":"0","endTime":"0","summary":"XBiotech (XBIT) announced that its investigational new drug, or IND, application for V-SPINE, a Phase II, double-blind, placebo-controlled, randomi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/xbiotech-to-enroll-patients-in-vilamakitug-trial-following-fda-review-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/xbiotech-to-enroll-patients-in-vilamakitug-trial-following-fda-review-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","BK4139","XBIT","IND","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643206760","title":"XBiotech Launches Phase II Clinical Trial Evaluating Vilamakitug for the Treatment of Active Axial Spondyloarthritis","url":"https://stock-news.laohu8.com/highlight/detail?id=2643206760","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643206760?lang=en_us&edition=fundamental","pubTime":"2026-06-15 21:00","pubTimestamp":1781528400,"startTime":"0","endTime":"0","summary":"IND Application for V-SPINE Study Completes 30-Day FDA Review Without Clinical Hold, Clearing Path for U.S. Patient Enrollment AUSTIN, Texas, June  15, 2026  (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/15/3311812/35550/en/XBiotech-Launches-Phase-II-Clinical-Trial-Evaluating-Vilamakitug-for-the-Treatment-of-Active-Axial-Spondyloarthritis.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314106906.USD","LU1244550221.USD","LU0310800965.SGD","XBIT","LU0162691827.USD","BK4588","LU1201861249.SGD","LU2125154935.USD","CUL3","LU2236285917.USD","LU1791807156.HKD","LU0320765646.SGD","BK4139","LU0648001328.SGD","LU0980610538.SGD","LU2360032135.SGD","LU0128525689.USD","BK4566","LU2417539215.USD","LU2462157665.USD","LU0052756011.USD","BK4585","LU1506573853.SGD","LU2456880835.USD","LU0098860793.USD","LU2125154778.USD","LU0203345920.USD","LU0130517989.USD","LU1668664300.SGD","BK4559","LU1162221912.USD","LU0477156953.USD","IND","BK4534","BK4504","LU1244550577.SGD","LU0130102774.USD","LU0072461881.USD","LU0170899867.USD","LU1244550494.USD","BK4207","LU0106831901.USD","LU1366192091.USD","IE00BSNM7G36.USD","LU1267930227.SGD","LU0203347892.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643219713","title":"HBM Holdings (SEHK:2142) Stock Valuation After New IND Milestone For Cancer Antibody HBM7004","url":"https://stock-news.laohu8.com/highlight/detail?id=2643219713","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643219713?lang=en_us&edition=fundamental","pubTime":"2026-06-13 11:28","pubTimestamp":1781321337,"startTime":"0","endTime":"0","summary":"HBM Holdings (SEHK:2142) is back in focus after China’s National Medical Products Administration accepted its investigational new drug filing for HBM7004, a bispecific antibody for advanced solid tumors, following earlier U.S. FDA clearance.\nSee our latest analysis for HBM Holdings.\nDespite the positive regulatory news, the stock’s recent momentum has cooled, with a 30 day share price return down 21.58% and the year to date share price return down 16.97%. This comes even as the 1 year total...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2142/hbm-holdings-shares/news/hbm-holdings-sehk2142-stock-valuation-after-new-ind-mileston","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2142/hbm-holdings-shares/news/hbm-holdings-sehk2142-stock-valuation-after-new-ind-mileston","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["02142","BK1161","HBM","DCF","DRAM","IND","BK1574","BK4168","BK4588","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642625428","title":"Shanghai Bao Pharma Wins U.S. FDA IND Clearance for First Subcutaneous Ceftriaxone Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2642625428","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642625428?lang=en_us&edition=fundamental","pubTime":"2026-06-10 19:01","pubTimestamp":1781089264,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals Co Ltd Class H ( ($HK:2659) ) has shared an update. Shanghai Bao Pharmaceuticals has secured U.S. FDA approval of an i...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/shanghai-bao-pharma-wins-u-s-fda-ind-clearance-for-first-subcutaneous-ceftriaxone-candidate?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/shanghai-bao-pharma-wins-u-s-fda-ind-clearance-for-first-subcutaneous-ceftriaxone-candidate?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","IND","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642848417","title":"HBM Wins China IND Nod for Bispecific Cancer Antibody HBM7004","url":"https://stock-news.laohu8.com/highlight/detail?id=2642848417","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642848417?lang=en_us&edition=fundamental","pubTime":"2026-06-10 12:37","pubTimestamp":1781066249,"startTime":"0","endTime":"0","summary":"HBM Holdings Ltd. ( ($HK:2142) ) has issued an announcement. HBM Holdings Ltd. announced that China’s National Medical Products Administration has ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/hbm-wins-china-ind-nod-for-bispecific-cancer-antibody-hbm7004?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/hbm-wins-china-ind-nod-for-bispecific-cancer-antibody-hbm7004?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4168","HBM","BK4588","IND","DRAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642415735","title":"Antengene Secures China IND Approval for Autoimmune Disease Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2642415735","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642415735?lang=en_us&edition=fundamental","pubTime":"2026-06-10 08:31","pubTimestamp":1781051482,"startTime":"0","endTime":"0","summary":"Antengene (HKG:6996) said China's National Medical Products Administration has approved an Investigational New Drug (IND) application for a Phase I study of ATG-201, according to a voluntary filing on","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IND.AU","BK7095","BK1191","IND","06996","BK1574","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642241315","title":"Antengene Wins China IND Nod for ATG-201 Autoimmune Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2642241315","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642241315?lang=en_us&edition=fundamental","pubTime":"2026-06-10 07:10","pubTimestamp":1781046659,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Antengene Corporation Limited ( ($HK:6996) ). Antengene has secured approval from China’s National Medical Prod...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/antengene-wins-china-ind-nod-for-atg-201-autoimmune-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/antengene-wins-china-ind-nod-for-atg-201-autoimmune-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192694235","title":"ANTENGENE-B Receives Chinese IND Approval for ATG-201 in Autoimmune Disease Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1192694235","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192694235?lang=en_us&edition=fundamental","pubTime":"2026-06-10 06:24","pubTimestamp":1781043854,"startTime":"0","endTime":"0","summary":"China's National Medical Products Administration has granted approval for the Investigational New Drug application for a Phase I study of ATG-201.ATG-201 is a CD19/CD3 bispecific T-cell engager...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","IND","06996","BK1583","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642494911","title":"Antelopus Selan Energy Secures IND A/Stable and IND A1 Ratings for INR 3,000 Million Loan Facilities","url":"https://stock-news.laohu8.com/highlight/detail?id=2642494911","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642494911?lang=en_us&edition=fundamental","pubTime":"2026-06-10 02:26","pubTimestamp":1781029589,"startTime":"0","endTime":"0","summary":"Selan Exploration Technology Limited ( ($IN:ANTELOPUS) ) has provided an update. Antelopus Selan Energy Limited has received new credit ratings fro...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/antelopus-selan-energy-secures-ind-a-stable-and-ind-a1-ratings-for-inr-3000-million-loan-facilities?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/antelopus-selan-energy-secures-ind-a-stable-and-ind-a1-ratings-for-inr-3000-million-loan-facilities?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642049581","title":"India Ratings Affirms RSWM at IND A, Revises Outlook to Stable","url":"https://stock-news.laohu8.com/highlight/detail?id=2642049581","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642049581?lang=en_us&edition=fundamental","pubTime":"2026-06-09 22:14","pubTimestamp":1781014440,"startTime":"0","endTime":"0","summary":"An announcement from RSWM Ltd ( ($IN:RSWM) ) is now available. RSWM Ltd has announced that India Ratings & Research has affirmed the company’s issu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/india-ratings-affirms-rswm-at-ind-a-revises-outlook-to-stable?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/india-ratings-affirms-rswm-at-ind-a-revises-outlook-to-stable?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IND","MNDmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159294168","title":"Modi's Third Term: India's Economic Growth Story Faces Its Most Severe Test Yet","url":"https://stock-news.laohu8.com/highlight/detail?id=1159294168","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159294168?lang=en_us&edition=fundamental","pubTime":"2026-06-09 18:11","pubTimestamp":1780999916,"startTime":"0","endTime":"0","summary":"Overseas securities investment institutions have sold a cumulative $29.5 billion worth of Indian equities so far this year, compared to nearly $19 billion for the entirety of last year.Experts note...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLIN","BK4523","INCO","INDA","PIN","FLIN","EMXC","NDIA","INDL","EPI","NFTY","IMVP","SMIN","INQQ","INDE","IND","INDY","BK4585","BK4588","SCIN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110254662","title":"Haisco Pharmaceutical Receives IND Application Acceptance for Novel Pain Drug HSK51155","url":"https://stock-news.laohu8.com/highlight/detail?id=1110254662","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110254662?lang=en_us&edition=fundamental","pubTime":"2026-06-09 16:28","pubTimestamp":1780993720,"startTime":"0","endTime":"0","summary":"Haisco Pharmaceutical Group Co.,Ltd. (002653.SZ) has announced the receipt of an acceptance notice from the National Medical Products Administration for its Investigational New Drug (IND) application...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["002653","BK0033","BK0239","BK1574","BK0028","IND","BK0077","06978","BK0188","159992","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172188048","title":"Chery Clarifies Nature of Partnership with Tata Group, Confirms No Direct Investment or Tech Transfer in India","url":"https://stock-news.laohu8.com/highlight/detail?id=1172188048","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172188048?lang=en_us&edition=fundamental","pubTime":"2026-06-08 17:20","pubTimestamp":1780910432,"startTime":"0","endTime":"0","summary":"Chery Automobile has issued a statement clarifying the nature of its ongoing discussions with India's Tata Group. The company stated that the potential cooperation agreement under negotiation is...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INDL","EPI","INDA","NDIA","INQQ","INDE","GLIN","SMIN","PIN","BK4585","FLIN","NFTY","SCIN","BK4588","INDY","INCO","IND","BK4523"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175018616","title":"World Gold Council Analyzes Impact of India's Tightened Gold Import Policies","url":"https://stock-news.laohu8.com/highlight/detail?id=1175018616","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175018616?lang=en_us&edition=fundamental","pubTime":"2026-06-08 15:41","pubTimestamp":1780904501,"startTime":"0","endTime":"0","summary":"The Indian market has implemented a significant tightening of gold import policies. In May, India's gold import duty was sharply increased by 9 percentage points, rising from 6% to 15%, marking the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLIN","SGUmain","159934","JNUG","UGL","518880","INDA","FLIN","NUGT","BK4504","DULL","JDST","INDL","MGCmain","SGCmain","YGLD","DGP","INDE","1OZmain","OUNZ","IND","GDXY","CEF","GBUG","IAUM","PIN","159831","DUST","GOAU","QOmain","DBC","BK4207","GOLY","AAAU","SMIN","UYM","GDX","INQQ","GCmain","INDY","SHNY","BK4588","DGZ","SGDM","GLDM","BGLD","IAU","INCO","BTGD","GDXU","BEGS","GDXJ","GLL","DZZ","XME","GDXD","GLD","SGOL","BK4585","SCIN","EPI","BK4523","PICK","BK4535","NDIA","RING","GLDY","NFTY","KGLD","IGLD","IAUI","BAR","USG","FGDL","PHYS","PALL","GLTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164656018","title":"USD/INR Holds High Amidst Fed Rate Hike Fears and Oil Price Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=1164656018","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164656018?lang=en_us&edition=fundamental","pubTime":"2026-06-08 15:22","pubTimestamp":1780903349,"startTime":"0","endTime":"0","summary":"The US dollar to Indian rupee pair continued its rebound during Monday's Asian trading session, with the exchange rate climbing near 95.60. A strong US dollar, rising international oil prices, and...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","US10Y.BOND","TLTW","US2Y.BOND","PIN","US12M.BOND","US30Y.BOND","US7Y.BOND","GLIN","EPI","NDIA","INDY","SMIN","TLT","INDL","NFTY","IMVP","INCO","INDA","INDE","US3Y.BOND","US5Y.BOND","TMF","BK4585","SCIN","INQQ","FLIN","IND","US6M.BOND","IUmain","BK4523"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130759338","title":"India's Central Bank Holds Rates, Unveils Measures to Support Rupee Amid Depreciation","url":"https://stock-news.laohu8.com/highlight/detail?id=1130759338","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130759338?lang=en_us&edition=fundamental","pubTime":"2026-06-05 15:40","pubTimestamp":1780645246,"startTime":"0","endTime":"0","summary":"India's central bank has introduced a series of measures to support the local currency after the rupee fell to a record low, while keeping its benchmark interest rate unchanged to underpin the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INDE","INDL","INCO","IND","SMIN","FLIN","NDIA","SCIN","BK4588","IMVP","NFTY","INQQ","BK4523","INDY","EPI","BK4585","INDA","PIN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162928555","title":"Reserve Bank of India Holds Rates Steady Amid Inflation and Growth Forecast Revisions","url":"https://stock-news.laohu8.com/highlight/detail?id=1162928555","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162928555?lang=en_us&edition=fundamental","pubTime":"2026-06-05 13:22","pubTimestamp":1780636966,"startTime":"0","endTime":"0","summary":"The Reserve Bank of India (RBI) held its key interest rate steady at 5.25% on Friday. This decision comes as surging global energy costs batter the Indian currency and the conflict in Iran risks...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EPI","FLIN","BK4588","INCO","INDA","BK4585","INDL","SCIN","IND","IMVP","INQQ","INDY","BK4523","INDE","PIN","SMIN","NFTY","NDIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149412908","title":"India's Central Bank Holds Key Interest Rate Steady, Signaling Reluctance to Hike for Rupee Support","url":"https://stock-news.laohu8.com/highlight/detail?id=1149412908","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149412908?lang=en_us&edition=fundamental","pubTime":"2026-06-05 13:00","pubTimestamp":1780635633,"startTime":"0","endTime":"0","summary":"The Reserve Bank of India has kept its policy rate unchanged, aligning with the expectations of most economists, as policymakers aim to provide a buffer for the economy while maintaining stability in...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INQQ","INDY","INDE","BK4585","INDL","BK4588","INDA","NDIA","IND","BK4523","EPI","SCIN","INCO","ZBmain","ZFmain","TNmain","ZNmain","SMIN","IMVP","FLIN","UBmain","NFTY","ZTmain","PIN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105114042","title":"India's Economic Resilience Tested by Energy Crisis","url":"https://stock-news.laohu8.com/highlight/detail?id=1105114042","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105114042?lang=en_us&edition=fundamental","pubTime":"2026-06-05 09:51","pubTimestamp":1780624315,"startTime":"0","endTime":"0","summary":"On May 10, Indian Prime Minister Narendra Modi appealed to the nation's more than 1.4 billion citizens at a public rally, urging them to reduce consumption of petrol and diesel and to curb their...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EMXC","NFTY","FLIN","SCIN","BK4523","INCO","IND","BK4588","GLIN","INDY","PIN","INDA","INDE","INQQ","EPI","IMVP","INDL","BK4585","SMIN","NDIA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}